For around 30% of all bowel cancer cases diagnosed there is a family history, hereditary contribution or a combination of both.
It is a disease that affects men and women of all ages, and its impact is felt not just by those diagnosed with the disease, but also by their loved ones.
“If you’re going to have cancer, Australia is a wonderful place to live,” said Mark Williams, following Minister for Health Greg Hunt’s announcement this morning at the Peter MacCallum Cancer Centre in Melbourne.
Beginning 1 December 2018, patients with metastatic bowel cancer (mCRC) will have another treatment option, with the subsidised listing of Lonsurf® (trifluridine with tipiracil) on the Pharmaceutical Benefits Scheme (PBS).
Mr Williams, age 55, has been living with metastatic bowel cancer since 2017.
“I know we talk about ‘hope’, but I’m living proof that these treatments can do a good job,” said Mr Williams who recently began taking Lonsurf®.
Get ready to grow - Bowel Cancer Australia’s annual Decembeard® campaign starts in two weeks!
Bowel cancer is Australia's second deadliest cancer and around 1 in 11 Aussie men will develop the disease in their lifetime.
Bowel Cancer Australia’s consistently high standard of work and services is only made possible through the generosity of our supporters and a shared commitment to championing what matters most to people affected by bowel cancer.
Bowel Cancer Australia provide practical and emotional support for the growing number of Australians affected by bowel cancer, building communities through shared experiences and creating a powerful voice for change.